» Articles » PMID: 36425530

The Roles of ING5 in Cancer: A Tumor Suppressor

Overview
Specialty Cell Biology
Date 2022 Nov 25
PMID 36425530
Authors
Affiliations
Soon will be listed here.
Abstract

As a Class II tumor suppressor, ING5 contains nuclear localization signal, plant homeodomain, novel conserved region, and leucine zipper-like domains. ING5 proteins form homodimer into a coil-coil structure, and heterodimers with ING4, histone H3K4me3, histone acetyltransferase (HAT) complex, Tip60, Cyclin A1/CDK2, INCA1 and EBNA3C for the transcription of target genes. The acetylated proteins up-regulated by ING5 are preferentially located in nucleus and act as transcription cofactors, chromatin and DNA binding functions, while those down-regulated by ING5 mostly in cytoplasm and contribute to metabolism. ING5 promotes the autoacetylation of HAT p300, p53, histone H3 and H4 for the transcription of downstream genes (Bax, GADD45, p21, p27 and so forth). Transcriptionally, YY1 and SRF up-regulate ING5 mRNA expression by the interaction of YY1-SRF-p53-ING5 complex with ING5 promoter. Translationally, ING5 is targeted by miR-196, miR-196a, miR-196b-5p, miR-193a-3p, miR-27-3p, miR-200b/200a/429, miR-1307, miR-193, miR-222, miR-331-3p, miR-181b, miR-543 and miR-196-b. ING5 suppresses proliferation, migration, invasion and tumor growth of various cancer cells the suppression of EGFR/PI3K/Akt, IL-6/STAT3, Akt/NF-κB/NF-κB/MMP-9 or IL-6/CXCL12 pathway. ING5-mediated chemoresistance is closely linked to anti-apoptosis, overexpression of chemoresistant genes, the activation of PI3K/Akt/NF-κB and Wnt/β-catenin signal pathways. Histologically, ING5 abrogation in gastric stem-like and pdx1-positive cells causes gastric dysplasia and cancer, and conditional ING5 knockout in pdx1-positive and gastric chief cells increases MNU-induced gastric carcinogenesis. Intestinal ING5 deletion increases AOM/DSS- induced colorectal carcinogenesis and decreases high-fat-diet weight. The overexpression and nucleocytoplasmic translocation of ING5 are seen during carcinogenesis, and ING5 expression was inversely associated with aggressive behaviors and poor prognosis in a variety of cancers. These findings indicated that ING5 might be used for a molecular marker for carcinogenesis and following progression, and as a target for gene therapy if its chemoresistant function might be ameliorated.

Citing Articles

Inhibitor of Growth Proteins: Epigenetic Regulators Shaping Neurobiology.

Xu Z, Xu H, Shi J, Liu R, Li X, Liu S Biomolecules. 2025; 15(2).

PMID: 40001584 PMC: 11852745. DOI: 10.3390/biom15020281.


Master Regulators of Causal Networks in Intestinal- and Diffuse-Type Gastric Cancer and the Relation to the RNA Virus Infection Pathway.

Tanabe S, Quader S, Cabral H, Perkins E, Yokozaki H, Sasaki H Int J Mol Sci. 2024; 25(16).

PMID: 39201509 PMC: 11354771. DOI: 10.3390/ijms25168821.


Expression of SDF-1/CXCR4 and related inflammatory factors in sodium fluoride-treated hepatocytes.

Yang R, Shen H, Wang M, Zhao Y, Zhu S, Jiang H PLoS One. 2024; 19(6):e0302530.

PMID: 38905184 PMC: 11192373. DOI: 10.1371/journal.pone.0302530.


Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.

Shen J, Wang Q, Mao Y, Gao W, Duan S MedComm (2020). 2023; 4(3):e288.

PMID: 37256211 PMC: 10225743. DOI: 10.1002/mco2.288.

References
1.
Zheng H, Xue H, Wu X, Xu H, Zhao E, Cui Z . Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer. Front Oncol. 2022; 12:918954. PMC: 9209732. DOI: 10.3389/fonc.2022.918954. View

2.
Chen W, Yang Y, Zhang Z, An Q, Li N, Liu W . MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression. J Ovarian Res. 2017; 10(1):1. PMC: 5234104. DOI: 10.1186/s13048-016-0301-4. View

3.
Dantas A, Al Shueili B, Yang Y, Nabbi A, Fink D, Riabowol K . Biological Functions of the ING Proteins. Cancers (Basel). 2019; 11(11). PMC: 6896041. DOI: 10.3390/cancers11111817. View

4.
Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y . ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer. 2017; 16(1):89. PMC: 5424299. DOI: 10.1186/s12943-017-0658-z. View

5.
He L, Yan R, Yang Z, Zhang Y, Liu X, Yang J . SCF is functionally linked to obesity and metabolic syndrome. EMBO Rep. 2021; 22(7):e52036. PMC: 8406403. DOI: 10.15252/embr.202052036. View